Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q1 FY26 results · Apr–Jun 2025
Metropolis Healthcare reported revenue from operations of ₹386.06 crore (up 23.2% from Q1 FY25) and net profit of ₹45.25 crore (up 18.7% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 386.06 | 313.36 | +23.2% | 345.29 | +11.8% |
| Other income | 7.52 | 2.46 | +205.8% | 6.97 | +7.8% |
| Total income | 393.58 | 315.81 | +24.6% | 352.26 | +11.7% |
| Profit before tax | 61.23 | 51.08 | +19.9% | 36.04 | +69.9% |
| Net profit for the period | 45.25 | 38.11 | +18.7% | 29.23 | +54.8% |
| Attributable to shareholders of the company | 45.06 | 37.95 | +18.7% | 29.14 | +54.6% |
| EPS, basic (₹) | 8.70 | 7.41 | +17.4% | 5.69 | +52.9% |
| Net margin (%) | 11.7 | 12.2 | 8.5 |
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 323.63 | 286.14 | +13.1% | 311.95 | +3.7% |
| Other income | 2.78 | 2.83 | −1.7% | 7.60 | −63.4% |
| Total income | 326.41 | 288.96 | +13.0% | 319.55 | +2.1% |
| Profit before tax | 47.68 | 41.72 | +14.3% | 28.64 | +66.5% |
| Net profit for the period | 35.58 | 31.28 | +13.8% | 23.85 | +49.2% |
| EPS, basic (₹) | 6.87 | 6.11 | +12.4% | 4.65 | +47.7% |
| Net margin (%) | 11.0 | 10.9 | 7.6 |
Consolidated
- Filed with BSE
- 07 Aug 2025, 18:10 IST
- Board meeting
- 07 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Aug 2025, 18:10 IST
- Board meeting
- 07 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE